Yüklüyor......
Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy
First-line chemotherapy to combat primary malignant brain cancer is often accompanied by lymphopenic immunologic deficiency. Although counterintuitive, chemotherapy-induced lymphopenia can provide excellent host conditioning that may actually be leveraged to potentiate antitumor immunotherapy. We di...
Kaydedildi:
Yayımlandı: | Oncoimmunology |
---|---|
Asıl Yazarlar: | , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Taylor & Francis
2014
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292586/ https://ncbi.nlm.nih.gov/pubmed/25610727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.944054 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|